These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
136 related items for PubMed ID: 6610686
1. Clinical evaluation of bone turnover by serum osteocalcin measurements in a hospital setting. Slovik DM, Gundberg CM, Neer RM, Lian JB. J Clin Endocrinol Metab; 1984 Aug; 59(2):228-30. PubMed ID: 6610686 [Abstract] [Full Text] [Related]
2. [Osteocalcin]. Galli M, Caniggia M. Minerva Med; 1984 Nov 03; 75(42):2489-501. PubMed ID: 6334818 [Abstract] [Full Text] [Related]
3. [Osteocalcin, a marker in diseases with elevated bone metabolism]. Stracke H, Schatz C, Pralle H, Ullmann J, Schatz H. Dtsch Med Wochenschr; 1985 Sep 20; 110(38):1442-6. PubMed ID: 3875469 [Abstract] [Full Text] [Related]
4. Serum osteocalcin concentrations in Paget's disease of bone. Wilkinson MR, Wagstaffe C, Delbridge L, Wiseman J, Posen S. Arch Intern Med; 1986 Feb 20; 146(2):268-71. PubMed ID: 3484940 [Abstract] [Full Text] [Related]
5. Serum bone GLA-protein is not a sensitive marker of bone turnover in Paget's disease of bone. Delmas PD, Demiaux B, Malaval L, Chapuy MC, Meunier PJ. Calcif Tissue Int; 1986 Jan 20; 38(1):60-1. PubMed ID: 3079654 [Abstract] [Full Text] [Related]
6. Non-invasive evaluation of bone formation: measurements of serum alkaline phosphatase, whole body retention of diphosphonate and serum osteocalcin in metabolic bone disorders and thyroid disease. Hyldstrup L, Clemmensen I, Jensen BA, Transbøl I. Scand J Clin Lab Invest; 1988 Nov 20; 48(7):611-9. PubMed ID: 3264412 [Abstract] [Full Text] [Related]
7. Concurrent assays of circulating bone Gla-protein and bone alkaline phosphatase: effects of sex, age, and metabolic bone disease. Duda RJ, O'Brien JF, Katzmann JA, Peterson JM, Mann KG, Riggs BL. J Clin Endocrinol Metab; 1988 May 20; 66(5):951-7. PubMed ID: 3258870 [Abstract] [Full Text] [Related]
8. Osteocalcin and bone remodelling in Paget's disease of bone, primary hyperparathyroidism, hypercalcaemia of malignancy and involutional osteoporosis. Torres R, de la Piedra C, Rapado A. Scand J Clin Lab Invest; 1989 May 20; 49(3):279-85. PubMed ID: 2787049 [Abstract] [Full Text] [Related]
9. Plasma osteocalcin in man. Melick RA, Farrugia W, Quelch KJ. Aust N Z J Med; 1985 Aug 20; 15(4):410-6. PubMed ID: 3878701 [Abstract] [Full Text] [Related]
10. Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease. Garnero P, Delmas PD. J Clin Endocrinol Metab; 1993 Oct 20; 77(4):1046-53. PubMed ID: 8104954 [Abstract] [Full Text] [Related]
11. New biochemical marker for bone metabolism. Measurement by radioimmunoassay of bone GLA protein in the plasma of normal subjects and patients with bone disease. Price PA, Parthemore JG, Deftos LJ. J Clin Invest; 1980 Nov 20; 66(5):878-83. PubMed ID: 6968755 [Abstract] [Full Text] [Related]
16. Evaluation of serum osteocalcin as an index of altered bone metabolism. Kruse K, Kracht U. Eur J Pediatr; 1986 Apr 20; 145(1-2):27-33. PubMed ID: 3015628 [Abstract] [Full Text] [Related]